# Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome

**Authors:** Martin C. Moncrieffe, Prasanna Suresh, Joe Boyle, Yuhao Cui, Bharti Nawalpuri, Brett Verstak, Yu P. Zhang, Ziwei Zhang, Marcus Taylor, Edward H. Egelman, Nicholas Gay, David Klenerman, Clare Bryant

PMC · DOI: 10.1126/sciadv.aeb9507 · 2026-03-06

## TL;DR

This study reveals how TRIF proteins form signaling platforms in immune cells, showing both new and existing mechanisms of immune response.

## Contribution

The study identifies TRIF's ability to form filamentous oligomers and reveals a previously unknown mode of TLR signaling.

## Key findings

- TRIF forms filamentous oligomers that associate with RIP1 and RIP3 kinases.
- TLR3/4 activation triggers interferon signaling before TRIFosome formation.
- TRIF is predominantly monomeric in unstimulated macrophages.

## Abstract

Toll-like receptors (TLRs) drive innate immunity via assembly of macromolecular signal transduction platforms [supramolecular organizing centers (SMOCs)] coordinated by adaptor proteins such as Toll/interleukin-1 receptor (IL-1R) domain–containing adaptor-inducing interferon-β (TRIF), but whether oligomeric TRIFosomes form is unknown. Here, using cryo–electron microscopy and biophysical characterization of full-length TRIF in vitro, we show that it forms filamentous oligomers, which associate with the TRIF signaling partners receptor interacting protein 1 (RIP1) and RIP3 kinases, suggesting that oligomeric TRIFosomes could form. Endogenous TRIF, however, is predominantly monomeric in the absence of ligand, only forming TRIFosome oligomers in macrophages after stimulation of TLR4 or TLR3 when large, macromolecular signaling complexes form. TRIFosomes are fully formed 45 min after TLR3 or 60 min after TLR4 stimulation, commensurate with activation of nuclear factor κB in these cells. TLR3/4 activation triggers rapid interferon signaling prior to TRIFosome formation through monomeric TRIF, unexpectedly suggesting that a macromolecular platform of TRIF is not required to drive this signaling pathway. Collectively, these data show TRIFosome macromolecular platform formation and, unexpectedly, that TLR signaling can be SMOC-independent in addition to being SMOC-dependent.

A previously entirely unknown mode of TLR signal transduction is elucidated.

## Linked entities

- **Genes:** TRIM69 (tripartite motif containing 69) [NCBI Gene 140691], UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1) [NCBI Gene 7386], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035]
- **Proteins:** TRIM69 (tripartite motif containing 69), UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1), RIPK3 (receptor interacting serine/threonine kinase 3), TLR4 (toll like receptor 4), TLR3 (toll like receptor 3)

## Full-text entities

- **Genes:** IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, TNF receptor associated factor 6 [NCBI Gene 222344], FUZ (fuzzy planar cell polarity protein) [NCBI Gene 80199] {aka CPLANE3, FY, NTD}, Ticam1 (TIR domain containing adaptor molecule 1) [NCBI Gene 106759] {aka TICAM-1, TRIF}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, TIRAP (TIR domain containing adaptor protein) [NCBI Gene 114609] {aka BACTS1, Mal, MyD88-2, wyatt}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, MAL (mal, T cell differentiation protein (MAL blood group)) [NCBI Gene 4118] {aka HLD28, MVP17, VIP17}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL1R1 (interleukin 1 receptor type 1) [NCBI Gene 3554] {aka CD121A, CRMO3, D2S1473, IL-1R-alpha, IL-1RT1, IL1R}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, TICAM1 (TIR domain containing adaptor molecule 1) [NCBI Gene 148022] {aka IIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874]
- **Diseases:** Infection (MESH:D007239), inflammation (MESH:D007249)
- **Chemicals:** Hepes (MESH:D006531), glycerol (MESH:D005990), penicillin (MESH:D010406), desthiobiotin (MESH:C004749), Abcam (-), amines (MESH:D000588), uranyl acetate (MESH:C005460), oil (MESH:D009821), F-127 (MESH:C078661), urea (MESH:D014508), TAK-242 (MESH:C507035), LPS (MESH:D008070), l-glutamine (MESH:D005973), CO2 (MESH:D002245), Tween 20 (MESH:D011136), PBS (MESH:D007854), Hydrogen (MESH:D006859), polyvinylidene difluoride (MESH:C024865), methanoic acid (MESH:C030544), MgCl2 (MESH:D015636), NaCl (MESH:D012965), proline (MESH:D011392), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), carbon (MESH:D002244), nickel (MESH:D009532), NP-40 (MESH:C010615), PMA (MESH:D013755), poly(I:C) (MESH:D011070), EDTA (MESH:D004492), Iodoacetamide (MESH:D007460), imidazole (MESH:C029899), ethane (MESH:D004980), water (MESH:D014867), DTT (MESH:D004229), Laemmli buffer (MESH:C088816), SDS (MESH:D012967), isopropanol (MESH:D019840)
- **Species:** Escherichia coli BL21(DE3) (strain) [taxon 469008], Homo sapiens (human, species) [taxon 9606], Tobacco etch virus (no rank) [taxon 12227], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** K50D, L51D, I539D, P434H, L49D
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965317/full.md

---
Source: https://tomesphere.com/paper/PMC12965317